Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination

Merus B.V. · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
colorectal-canceresophageal-squamous-cell-carcinomagastric-cancerhead-and-neck-cancernsclc
non-small cell lung cancer metastatic, gastric cancer, esophageal squamous cell carcinoma, head and neck squamous cell carcinoma, colorectal cancer, mcla-129, egfr inhibitor, nsclc, c-met, gc/gej, head and neck cancer, interventional
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 979820
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.